Nota Bene Cancer
Nota Bene Cancer est un bulletin hebdomadaire de veille bibliographique. En libre accès, Nota Bene Cancer permet à ses abonnés de gagner du temps pour se tenir informé de l’actualité scientifique et médicale dans les divers domaines de la recherche sur les cancers.
Pour retrouver les publications signalées par Nota Bene Cancer (archives indexées à partir du n°127 du 1" mars 2012) :
Sommaire du n° 556 du 6 mars 2023
Qualité de vie, soins de support (2)
Menée par enquête auprès de 56 patients atteints d'un cancer du pancréas, cette étude analyse l'association entre l'activation comportementale du patient et sa qualité de vie
Evaluating the relationship between patient activation and health-related quality of life (HRQOL) in patients with pancreatic cancer (PwPC)
Menée par enquête auprès de 56 patients atteints d'un cancer du pancréas, cette étude analyse l'association entre l'activation comportementale du patient et sa qualité de vie
Evaluating the relationship between patient activation and health-related quality of life (HRQOL) in patients with pancreatic cancer (PwPC)
Vohra, Yogesh ; Brown, Carolyn M. ; Moczygemba, Leticia R. ; Wilfong, Lalan
Purpose: Advanced pancreatic cancer is synonymous with a high mortality rate, debilitating symptom profile, and minimal prolongation in overall survival. Therefore, health-related quality of life (HRQOL) is important in patients with pancreatic cancer (PwPC). In chronic conditions, patient activation is positively associated and higher HRQOL. However, no known study has evaluated patient activation, HRQOL, and their association in PwPC. Methods: A 43-item cross-sectional survey assessed patient [...]
A partir d'une revue systématique de la littérature publiée entre 1946 et 2020 (5 essais randomisés contrôlés), cette méta-analyse évalue l'effet d'une utilisation de déodorant ou d'anti-transpirant sur le développement d'une radiodermite aiguë chez des patientes atteintes d'un cancer du sein pendant la radiothérapie
The effect of antiperspirant and deodorant use on acute radiation dermatitis in breast cancer patients during radiotherapy: a systematic review and...
A partir d'une revue systématique de la littérature publiée entre 1946 et 2020 (5 essais randomisés contrôlés), cette méta-analyse évalue l'effet d'une utilisation de déodorant ou d'anti-transpirant sur le développement d'une radiodermite aiguë chez des patientes atteintes d'un cancer du sein pendant la radiothérapie
The effect of antiperspirant and deodorant use on acute radiation dermatitis in breast cancer patients during radiotherapy: a systematic review and meta-analysis
Salvestrini, Viola ; Marta, Gustavo Nader ; Caini, Saverio ; Wolf, Julie Ryan ; van den Hurk, Corina ; Beveridge, Mara ; Lam, Henry ; Bonomo, Pierluigi ; Chow, Edward ; Behroozian, Tara
Purpose: While some authors have investigated the impact of antiperspirant /deodorant on the development of acute radiation dermatitis (RD) among patients undergoing radiotherapy (RT) for breast cancer, recommendations supporting the use of antiperspirant/deodorant during breast RT remain highly variable. This systematic review and meta-analysis aims to evaluate the evidence investigating the effect of antiperspirant/deodorant on the development of acute RD during post-operative breast RT. [...]
Observation (7)
Ce dossier présente un ensemble d'articles concernant la prise en charge des cancers durant la crise sanitaire liée à la COVID-19
Understanding the Impact of COVID-19 on Chronic Lymphocytic Leukemia (CLL) Caregiving and Related Resource Needs
Ce dossier présente un ensemble d'articles concernant la prise en charge des cancers durant la crise sanitaire liée à la COVID-19
Understanding the Impact of COVID-19 on Chronic Lymphocytic Leukemia (CLL) Caregiving and Related Resource Needs
Bagautdinova, Diliara ; Bacharz, Kelsey C. ; Bylund, Carma L. ; Sae-Hau, Maria ; Weiss, Elisa S. ; Rajotte, Michelle ; Lincoln, Greg ; Vasquez, Taylor S. ; Parker, Naomi D. ; Wright, Kevin B. ; Fisher, Carla L.
Chronic lymphocytic leukemia (CLL) caregivers play a central role in disease management—a role that has been heightened during the COVID-19 pandemic given the healthcare system’s reliance on frontline family caregivers and CLL patients’ increased risk of infection and mortality. Using a mixed-method design, we investigated the impact of the pandemic on CLL caregivers (Aim 1) and their perceived resource needs (Aim 2): 575 CLL caregivers responded to an online survey; 12 spousal CLL caregivers [...]
The Humoral Response of Patients With Cancer to Breakthrough COVID-19 Infection or the Fourth BNT162b2 Vaccine Dose
Ce dossier présente un ensemble d'articles concernant la prise en charge des cancers durant la crise sanitaire liée à la COVID-19
The Humoral Response of Patients With Cancer to Breakthrough COVID-19 Infection or the Fourth BNT162b2 Vaccine Dose
Cohen, Idan ; Campisi-Pfinto, Salvatore ; Rozenberg, Orit ; Colodner, Raul ; Bar-Sela, Gil
Since January 2022 in Israel, high-risk populations with underlying health conditions were advised to receive a fourth dose of the BNT162b2 vaccine (Pfizer-BioNTech) against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). We monitored vaccine-induced immunity among oncology patients undergoing systemic anti-cancer therapy before and after the 4th-BNT162b2-dose. Three groups of patients were included in the study: those who received 3rd-BNT162b2-dose and had no breakthrough [...]
mRNA—From COVID-19 Treatment to Cancer Immunotherapy
Ce dossier présente un ensemble d'articles concernant la prise en charge des cancers durant la crise sanitaire liée à la COVID-19
mRNA—From COVID-19 Treatment to Cancer Immunotherapy
Krause, Werner
This review provides an overview covering mRNA from its use in the COVID-19 pandemic to cancer immunotherapy, starting from the selection of appropriate antigens, tumor-associated and tumor-specific antigens, neoantigens, the basics of optimizing the mRNA molecule in terms of stability, efficacy, and tolerability, choosing the best formulation and the optimal route of administration, to summarizing current clinical trials of mRNA vaccines in tumor therapy.
The Mental Health Burden of Patients with Colorectal Cancer Receiving Care during the COVID-19 Pandemic: Results of the PICO-SM Study
Ce dossier présente un ensemble d'articles concernant la prise en charge des cancers durant la crise sanitaire liée à la COVID-19
The Mental Health Burden of Patients with Colorectal Cancer Receiving Care during the COVID-19 Pandemic: Results of the PICO-SM Study
Lim, Kok Haw Jonathan ; Ntellas, Panagiotis ; Anderson, Daniel ; Simpson, Lilly ; Braun, Michael ; Adamou, Marios ; Barriuso, Jorge ; Dadouli, Katerina ; Connell, Jacqueline ; Williams, Joseph ; Germetaki, Theodora ; Lehwald, Deirdre ; Fitzpatrick, Niall ; Cutting, Mark ; McCool, Danielle ; Hasan, Jurjees ; Mullamitha, Saifee ; Marti, Kalena ; Saunders, Mark ; Kamposioras, Konstantinos
The COVID-19 pandemic has resulted in unprecedented changes to the life of patients with cancer. In this study, we aim to evaluate the impact of the COVID-19 pandemic on the mental health and general well-being of patients with colorectal cancer by carrying out a prospective longitudinal questionnaire. We found that around one in four participants reported symptoms of anxiety and poor well-being, with 15% at risk of moderate to severe depression. Amongst others, those who were worried that the [...]
Anticancer Therapy and Mortality of Adult Patients with Hematologic Malignancy and COVID-19: A Systematic Review and Meta-Analysis
Ce dossier présente un ensemble d'articles concernant la prise en charge des cancers durant la crise sanitaire liée à la COVID-19
Anticancer Therapy and Mortality of Adult Patients with Hematologic Malignancy and COVID-19: A Systematic Review and Meta-Analysis
Lin, Wen-Li ; Nguyen, Thi-Hoang-Yen ; Wu, Li-Min ; Huang, Wen-Tsung ; Su, Shih-Bin
Coronavirus disease 2019 (COVID-19) might affect cancer treatment outcomes. This systematic review and meta-analysis identified the prognostic predictors of adult patients with hematologic malignancies and COVID-19, and evaluated the effect of anticancer therapy on mortality. We performed a literature search of electronic databases and identified additional studies from the bibliographies of the articles that were retrieved. Two investigators independently extracted data according to the [...]
Impact of the COVID-19 pandemic on cancer care in Ireland – Perspectives from a COVID-19 and Cancer Working Group
Ce dossier présente un ensemble d'articles concernant la prise en charge des cancers durant la crise sanitaire liée à la COVID-19
Impact of the COVID-19 pandemic on cancer care in Ireland – Perspectives from a COVID-19 and Cancer Working Group
O'Reilly, Seamus ; Kathryn Carroll, Hailey ; Murray, Deirdre ; Burke, Louise ; McCarthy, Triona ; O’Connor, Robert ; Kilty, Claire ; Lynch, Sonya ; Feighan, Jennifer ; Cloherty, Maeve ; Fitzpatrick, Patricia ; Falvey, Katrina ; Murphy, Verena ; Jane O'Leary, Mary ; Gregg, Sophie ; Young, Leonie ; McAuliffe, Eilish ; Hegarty, Josephine ; Gavin, Anna ; Lawler, Mark ; Kavanagh, Paul ; Spillane, Susan ; McWade, Terry ; Heffron, Mairead ; Ryan, Karen ; Kelly, Paul ; Murphy, Aileen ; Corrigan, Mark ; Redmond, H. Paul ; Redmond, Patrick ; Walsh, Paul ; Tierney, Paula ; Zhang, Mengyang ; Bennett, Kathleen ; Mullooly, Maeve
Upon the COVID-19 pandemic onset in Ireland, cancer service disruptions occurred due to prioritisation of COVID-19 related care, redeployment of staff, initial pausing of screening, diagnostic, medical and surgical oncology procedures, staff shortages due to COVID-19 infection and impacts on the physical and mental health of cancer healthcare workers. This was coupled with reluctance among people with symptoms suspicious for cancer to attend for clinical evaluation, due to concerns of [...]
Influence of COVID-19 Pandemic on Colorectal Cancer Presentation, Management and Outcome during the COVID-19 Pandemic
Ce dossier présente un ensemble d'articles concernant la prise en charge des cancers durant la crise sanitaire liée à la COVID-19
Influence of COVID-19 Pandemic on Colorectal Cancer Presentation, Management and Outcome during the COVID-19 Pandemic
Pirozzi, B. M. ; Siragusa, L. ; Baldini, G. ; Pellicciaro, M. ; Grande, M. ; Efrati, C. ; Finizio, R. ; Formica, V. ; Del Vecchio Blanco, G. ; Sica, G. S.
The aim of the study was to investigate whether the COVID-19 pandemic and related measures had an influence on colorectal cancer (CRC) presentation, management, and outcomes; it was a retrospective monocentric study. CRC patients undergoing surgery during the COVID-19 pandemic (1 March 2020–28 February 2022) (group B) were compared with patients operated on in the previous two years (1 March 2018–29 February 2020) in the same unit (group A). The primary outcome was to investigate whether there [...]
Effectiveness of nirmatrelvir plus ritonavir treatment for patients with CLL during the Omicron Surge
Ce dossier présente un ensemble d'articles concernant la prise en charge des cancers durant la crise sanitaire liée à la COVID-19
Effectiveness of nirmatrelvir plus ritonavir treatment for patients with CLL during the Omicron Surge
Tadmor, Tamar ; Alapi, Hillel ; Rokach, Lior
Patients with CLL, even in the omicron era and post-vaccination, suffer from persistent covid, higher complications and mortality compared to the general population. In the current study, we evaluated retrospectively the effectiveness of Nirmatrelvir plus ritonavir among 1,080 patients with CLL that were infected with SARS-CoV-2. Nirmatrelvir administration was associated with a reduction in Covid-19-related hospitalization or death by day 35. Specifically, the rate of Covid-19-related [...]
Impact of COVID-19 Pandemic on Frontline Pembrolizumab-Based Treatment for Advanced Lung Cancer
Ce dossier présente un ensemble d'articles concernant la prise en charge des cancers durant la crise sanitaire liée à la COVID-19
Impact of COVID-19 Pandemic on Frontline Pembrolizumab-Based Treatment for Advanced Lung Cancer
Tanvetyanon, Tawee ; Chen, Dung-Tsa ; Gray, Jhanelle E.
Background: Pembrolizumab monotherapy or pembrolizumab plus chemotherapy has become an important frontline treatment for advanced non-small cell lung cancer (NSCLC). To date, it remains unclear how the coronavirus disease 2019 (COVID-19) pandemic impacted the treatment outcome. Methods: A quasi-experimental study was conducted based on a real-world database, comparing pandemic with pre-pandemic patient cohorts. The pandemic cohort consisted of patients who initiated treatment from March to July [...]
The Impact of the Early COVID-19 Global Pandemic on Children Undergoing Active Cancer Treatment and Their Parents
Ce dossier présente un ensemble d'articles concernant la prise en charge des cancers durant la crise sanitaire liée à la COVID-19
The Impact of the Early COVID-19 Global Pandemic on Children Undergoing Active Cancer Treatment and Their Parents
Tran, Andrew ; Hou, Sharon H. J. ; Forbes, Caitlin ; Cho, Sara ; Forster, Victoria J. ; Stokoe, Mehak ; Wakefield, Claire E. ; Wiener, Lori ; Heathcote, Lauren C. ; Michel, Gisela ; Patterson, Pandora ; Reynolds, Kathleen ; Schulte, Fiona S. M.
Background: The COVID-19 global pandemic has impacted people worldwide with unique implications for vulnerable groups. In this cross-sectional study, we examined the impact of the early pandemic on children undergoing active cancer treatment and their parents. (2) Methods: In May 2020, 30 parents of children undergoing active cancer treatment completed an online survey regarding the impact of COVID-19 on their child’s cancer care, perceived utility of telemedicine, and child and parent mental [...]
The Effect of Vinyasa Yoga Practice on the Well-Being of Breast-Cancer Patients during COVID-19 Pandemic
Ce dossier présente un ensemble d'articles concernant la prise en charge des cancers durant la crise sanitaire liée à la COVID-19
The Effect of Vinyasa Yoga Practice on the Well-Being of Breast-Cancer Patients during COVID-19 Pandemic
Zok, Agnieszka ; Matecka, Monika ; Zapala, Joanna ; Izycki, Dariusz ; Baum, Ewa
Background: Vinyasa yoga practice improves body fitness and potentially positively affects practitioners’ well-being and health. Due to the diverse intensity of practice and positions customized to the practitioner’s needs, it can also support cancer patients. Undertaking physical activity that has a potentially positive effect on well-being and health was particularly important during the self-isolation that followed the COVID-19 pandemic. The purpose of this study was to evaluate the impact [...]
Menée au Canada à partir de données portant sur 2 737 patients âgés atteints d'un cancer (âge : supérieur ou égal à 65 ans), cette étude analyse l'association entre une utilisation d'antibiotiques antérieure au traitement par inhibiteurs de points de contrôle immunitaire et la survie globale
Impact of Antibiotic Exposure Before Immune Checkpoint Inhibitor Treatment on Overall Survival in Older Adults With Cancer: A Population-Based Study
Menée au Canada à partir de données portant sur 2 737 patients âgés atteints d'un cancer (âge : supérieur ou égal à 65 ans), cette étude analyse l'association entre une utilisation d'antibiotiques antérieure au traitement par inhibiteurs de points de contrôle immunitaire et la survie globale
Impact of Antibiotic Exposure Before Immune Checkpoint Inhibitor Treatment on Overall Survival in Older Adults With Cancer: A Population-Based Study
Lawson Eng ; Rinku Sutradhar ; Yue Niu ; Ning Liu ; Ying Liu ; Yosuf Kaliwal ; Melanie L. Powis ; Geoffrey Liu ; Jeffrey M. Peppercorn ; Philippe L. Bedard ; Monika K. Krzyzanowska
PURPOSE: Antibiotic exposure before immune checkpoint inhibitor (ICI) treatment can negatively affect outcomes through alteration in the gut microbiome, but large-scale evaluations are lacking. We performed a population-level retrospective cohort study to evaluate the impact of antibiotic exposure before starting ICI on overall survival (OS). PATIENT AND METHODS: Patients with cancer, age 65 years or older, who initiated treatment with ICIs between June 2012 and October 2018 in Ontario, Canada, [...]
Antibiotic Therapy: The Cornerstone of Iatrogenic Resistance to Immune Checkpoint Inhibitors
Menée au Canada à partir de données portant sur 2 737 patients âgés atteints d'un cancer (âge : supérieur ou égal à 65 ans), cette étude analyse l'association entre une utilisation d'antibiotiques antérieure au traitement par inhibiteurs de points de contrôle immunitaire et la survie globale
Antibiotic Therapy: The Cornerstone of Iatrogenic Resistance to Immune Checkpoint Inhibitors
David J. Pinato ; Alessio Cortellini
The past decade has been testament to the diffusion of immune checkpoint inhibitors (ICIs) as part of the therapeutic armamentarium of nearly every oncologic indication. The unquestionable advances in the management of solid and hematologic malignancies ushered by selective modulation of programmed cell-death 1, cytotoxic T-lymphocyte–associated protein 4, and a growing additional number of putative actionable drivers of anticancer immunity have been accompanied by the compelling need to [...]
Menée au Royaume-Uni sur la période 1997-2001 à partir de données portant sur 2 674 patients pédiatriques atteints d'un cancer (âge : 0-14 ans), cette étude analyse les disparités ethniques et socio-économiques dans la survie
Socio-economic and ethnic disparities in childhood cancer survival, Yorkshire, UK
Menée au Royaume-Uni sur la période 1997-2001 à partir de données portant sur 2 674 patients pédiatriques atteints d'un cancer (âge : 0-14 ans), cette étude analyse les disparités ethniques et socio-économiques dans la survie
Socio-economic and ethnic disparities in childhood cancer survival, Yorkshire, UK
Cromie, K. J. ; Hughes, N. F. ; Milner, S. ; Crump, P. ; Grinfeld, J. ; Jenkins, A. ; Norman, P. D. ; Picton, S. V. ; Stiller, C. A. ; Yeomanson, D. ; Glaser, A. W. ; Feltbower, R. G.
Background: Establishing the existence of health inequalities remains a high research and policy agenda item in the United Kingdom. We describe ethnic and socio-economic differences in paediatric cancer survival, focusing specifically on the extent to which disparities have changed over a 20-year period. Methods: Cancer registration data for 2674 children (0–14 years) in Yorkshire were analysed. Five-year survival estimates by ethnic group (south Asian/non-south Asian) and Townsend deprivation [...]
Menée aux Pays-Bas à partir de données portant sur 10 689 patients traités pour un cancer de l'oesophage ou d'un cancer de l'estomac diagnostiqués entre 2006 et 2020, cette étude analyse la survie relative conditionnelle à 3 ans
Conditional relative survival in non-metastatic esophagogastric cancer between 2006 and 2020: a population-based study
Menée aux Pays-Bas à partir de données portant sur 10 689 patients traités pour un cancer de l'oesophage ou d'un cancer de l'estomac diagnostiqués entre 2006 et 2020, cette étude analyse la survie relative conditionnelle à 3 ans
Conditional relative survival in non-metastatic esophagogastric cancer between 2006 and 2020: a population-based study
Pape, Marieke ; Kuijper, Steven C. ; Vissers, Pauline A.J. ; Ruurda, Jelle P. ; Neelis, Karen J. ; van Laarhoven, Hanneke W.M. ; Verhoeven, Rob H.A.
Conditional relative survival (CRS) is useful for communicating prognosis to patients as it provides an estimate of the life expectancy after having survived a certain time after treatment. This study estimates the three year relative survival conditional on having survived a certain period for patients with esophageal or gastric cancer. Patients with non-metastatic esophageal or gastric cancer diagnosed between 2006-2020 treated with curative intent (resection with or without (neo)adjuvant [...]
Menée aux Etats-Unis, cette étude présente, pour l'année 2023, des projections d'incidence du cancer colorectal et de la mortalité associée
Colorectal cancer statistics, 2023
Menée aux Etats-Unis, cette étude présente, pour l'année 2023, des projections d'incidence du cancer colorectal et de la mortalité associée
Colorectal cancer statistics, 2023
Siegel, Rebecca L. ; Wagle, Nikita Sandeep ; Cercek, Andrea ; Smith, Robert A. ; Jemal, Ahmedin
Colorectal cancer (CRC) is the second most common cause of cancer death in the United States. Every 3 years, the American Cancer Society provides an update of CRC statistics based on incidence from population-based cancer registries and mortality from the National Center for Health Statistics. In 2023, approximately 153,020 individuals will be diagnosed with CRC and 52,550 will die from the disease, including 19,550 cases and 3750 deaths in individuals younger than 50 years. The decline in CRC [...]
Menée à partir de données portant sur 218 patients pédiatriques atteints d'un rhabdomyosarcome orbitaire ou palpébral et inclus dans des essais entre 1997 et 2013, cette étude analyse la survie sans événement et la survie globale
Survival of patients with orbital and eyelid rhabdomyosarcoma treated on Children's Oncology Group studies from 1997 to 2013: A report from the Chi...
Menée à partir de données portant sur 218 patients pédiatriques atteints d'un rhabdomyosarcome orbitaire ou palpébral et inclus dans des essais entre 1997 et 2013, cette étude analyse la survie sans événement et la survie globale
Survival of patients with orbital and eyelid rhabdomyosarcoma treated on Children's Oncology Group studies from 1997 to 2013: A report from the Children's Oncology Group
Metts, Jonathan ; Xue, Wei ; Gao, Zhengya ; Ermoian, Ralph ; Bradley, Julie A. ; Arnold, Michael A. ; Dasgupta, Roshni ; Venkatramani, Rajkumar ; Walterhouse, David
Background : Orbital rhabdomyosarcoma (ORMS) commonly presents as low-risk disease (stage 1, group I–III, embryonal RMS) with excellent outcome. Long-term follow-up of patients with low-risk ORMS and outcomes of less common subgroups of ORMS treated on recent Children's Oncology Group (COG) trials have not been reported. Methods: Patients with ORMS enrolled on COG trials from 1997 to 2013 were identified. Demographic information and disease characteristics were collected. Outcomes were [...]
Menée aux Etats-Unis, cette étude analyse les données relatives à l'incidence du glioblastome et d'autres tumeurs cérébrales primitives chez l'adulte puis examine l'efficacité de différentes stratégies thérapeutiques
Glioblastoma and Other Primary Brain Malignancies in Adults: A Review
Menée aux Etats-Unis, cette étude analyse les données relatives à l'incidence du glioblastome et d'autres tumeurs cérébrales primitives chez l'adulte puis examine l'efficacité de différentes stratégies thérapeutiques
Glioblastoma and Other Primary Brain Malignancies in Adults: A Review
Schaff, Lauren R. ; Mellinghoff, Ingo K.
Importance : Malignant primary brain tumors cause more than 15 000 deaths per year in the United States. The annual incidence of primary malignant brain tumors is approximately 7 per 100 000 individuals and increases with age. Five-year survival is approximately 36%. Observations : Approximately 49% of malignant brain tumors are glioblastomas, and 30% are diffusely infiltrating lower-grade gliomas. Other malignant brain tumors include primary central nervous system (CNS) lymphoma (7%) and [...]
Approches psycho-sociales (1)
A partir d'une revue systématique de la littérature publiée entre 2018 et 2020 (25 revues et 76 articles), cette méta-revue analyse les expériences psychosociales des patientes ayant survécu à un cancer du sein
Psychosocial experiences of breast cancer survivors: a meta-review
A partir d'une revue systématique de la littérature publiée entre 2018 et 2020 (25 revues et 76 articles), cette méta-revue analyse les expériences psychosociales des patientes ayant survécu à un cancer du sein
Psychosocial experiences of breast cancer survivors: a meta-review
R, King ; L, Stafford ; P, Butow ; S, Giunta ; R, Laidsaar-Powell
Purpose: Advances in breast cancer care have led to a high rate of survivorship. This meta-review (systematic review of reviews) assesses and synthesises the voluminous qualitative survivorship evidence-base, providing a comprehensive overview of the main themes regarding breast cancer survivorship experiences, and areas requiring further investigation. Methods: Sixteen breast cancer reviews identified by a previous mixed cancer survivorship meta-review were included, with additional reviews [...]
Analyses économiques et systèmes de soins (1)
Menée aux Etats-Unis, cette étude estime, pour l'année 2019, les coûts associés au cancer chez les adolescents et jeunes adultes ayant survécu à la maladie (âge : 15-39 ans)
Cost of Cancer in Adolescents and Young Adults in the United States: Results of the 2021 Report by Deloitte Access Economics, Commissioned by Teen...
Menée aux Etats-Unis, cette étude estime, pour l'année 2019, les coûts associés au cancer chez les adolescents et jeunes adultes ayant survécu à la maladie (âge : 15-39 ans)
Cost of Cancer in Adolescents and Young Adults in the United States: Results of the 2021 Report by Deloitte Access Economics, Commissioned by Teen Cancer America
Susan K. Parsons ; Theresa H.M. Keegan ; Anne C. Kirchhoff ; Helen M. Parsons ; K. Robin Yabroff ; Simon J. Davies
PURPOSE: The purpose of this report, commissioned by Teen Cancer America and performed by Deloitte Access Economics in 2021, was to estimate the total costs incurred by adolescent and young adults (AYAs) after cancer diagnosis in the United States (US) over their life course. METHODS: The incidence of cancer in 2019 among AYAs age 15-39 years was estimated from the US Cancer Statistics Public Use Database, and relative survival was projected from the Surveillance, Epidemiology, and End Results [...]
Sensibilisation et communication (1)
A partir d'une revue systématique de la littérature publiée jusqu'en janvier 2022 (22 études), cette étude analyse les messages pédagogiques et les stratégies de communication pour améliorer les connaissances du grand public et des professionnels de santé concernant le dépistage du cancer du poumon
Education messages and strategies to inform the public, potential screening candidates and healthcare providers about lung cancer screening: A syst...
A partir d'une revue systématique de la littérature publiée jusqu'en janvier 2022 (22 études), cette étude analyse les messages pédagogiques et les stratégies de communication pour améliorer les connaissances du grand public et des professionnels de santé concernant le dépistage du cancer du poumon
Education messages and strategies to inform the public, potential screening candidates and healthcare providers about lung cancer screening: A systematic review
Dodd, Rachael H. ; Sharman, Ashleigh R. ; McGregor, Deborah ; Stone, Emily ; Donnelly, Candice ; Lourenco, Richard De Abreu ; Marshall, Henry ; Rankin, Nicole M.
International lung cancer screening (LCS) trials, using low-dose computed tomography, have demonstrated clinical effectiveness in reducing mortality from lung cancer. This systematic review aims to synthesise the key messages and strategies that could be successful in increasing awareness and knowledge of LCS, and ultimately increase uptake of screening. Studies were identified via relevant database searches up to January 2022. Two authors evaluated eligible studies, extracted and crosschecked [...]
Soins palliatifs (1)
Menée aux Etats-Unis par enquête auprès de 70 patients atteints d'un cancer du poumon de stade avancé, cette étude analyse les facteurs associés à l'utilisation de soins palliatifs selon le lieu de prise en charge
Palliative care use and utilization determinants among patients treated for advanced stage lung cancer care in the community and academic medical s...
Menée aux Etats-Unis par enquête auprès de 70 patients atteints d'un cancer du poumon de stade avancé, cette étude analyse les facteurs associés à l'utilisation de soins palliatifs selon le lieu de prise en charge
Palliative care use and utilization determinants among patients treated for advanced stage lung cancer care in the community and academic medical setting
McLouth, Laurie E. ; Borger, Tia ; Bursac, Vilma ; Hoerger, Michael ; McFarlin, Jessica ; Shelton, Shaylla ; Shelton, Brent ; Shearer, Andrew ; Kiviniemi, Marc T. ; Stapleton, Jerod L. ; Mullett, Timothy ; Studts, Jamie L. ; Goebel, David ; Thind, Ravneet ; Trice, Laura ; Schoenberg, Nancy E.
Purpose: Despite clinical guidelines, palliative care is underutilized during advanced stage lung cancer treatment. To inform interventions to increase its use, patient-level barriers and facilitators (i.e., determinants) need to be characterized, especially among patients living in rural areas or those receiving treatment outside academic medical centers. Methods: Between 2020 and 2021, advanced stage lung cancer patients (n = 77; 62% rural; 58% receiving care in the community) completed a [...]